State Medicaid programs did not make use of prior authorization to promote safer prescribing after rosiglitazone warning

scientific article

State Medicaid programs did not make use of prior authorization to promote safer prescribing after rosiglitazone warning is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1377/HLTHAFF.2011.1068
P932PMC publication ID3319744
P698PubMed publication ID22232110
P5875ResearchGate publication ID221735581

P50authorVictor MontoriQ7926167
Harlan M. KrumholzQ28211478
Joseph S. RossQ42409824
G Caleb AlexanderQ89450189
Cynthia A JackeviciusQ92575259
P2093author name stringNilay D Shah
Jiaquan Fan
Judy Zerzan
Jennifer Ridgeway
P2860cites workComparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinationsQ22241134
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular CausesQ22250883
Changes in glitazone use among office-based physicians in the U.S., 2003-2009.Q33751542
Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitorsQ35952860
Impact of Medicaid prior authorization on angiotensin-receptor blockers: can policy promote rational prescribing?Q36814187
Rosiglitazone and pioglitazone utilization from January 2007 through May 2008 associated with five risk-warning eventsQ37240896
Impact of rosiglitazone meta-analysis on use of glucose-lowering medications.Q41807349
Responding to an FDA warning--geographic variation in the use of rosiglitazoneQ42806869
Thiazolidinediones and the influence of media adverse reporting on prescribing attitudes in practice (TZD-IMPACT) study.Q46020139
Physicians' prescribing responses to a restricted formulary: the impact of Medicaid preferred drug lists in Illinois and LouisianaQ46345430
TESTING FOR SERIAL CORRELATION IN LEAST SQUARES REGRESSION. IIQ57253959
Switching From RosiglitazoneQ57255282
What have we learnt from the rosiglitazone saga?Q57277619
A community intervention trial to promote judicious antibiotic use and reduce penicillin-resistant Streptococcus pneumoniae carriage in childrenQ74454449
Segmented regression analysis of interrupted time series studies in medication use researchQ74601008
Benefits and risks of increasing restrictions on access to costly drugs in MedicaidQ79738054
Medicaid's prior authorization program and access to atypical antipsychotic medicationsQ80281221
P433issue1
P407language of work or nameEnglishQ1860
P921main subject(RS)-rosiglitazoneQ424771
P304page(s)188-98
P577publication date2012-01-01
P1433published inHealth AffairsQ260110
P1476titleState Medicaid programs did not make use of prior authorization to promote safer prescribing after rosiglitazone warning
P478volume31

Reverse relations

cites work (P2860)
Q34495367Association between unemployment rates and prescription drug utilization in the United States, 2007-2010.
Q36728428Disparities in Discontinuing Rosiglitazone Following the 2007 FDA Safety Alert.
Q44349603Effect of a High Dosage Opioid Prior Authorization Policy on Prescription Opioid Use, Misuse, and Overdose Outcomes.
Q30359158Geographic Variation in Rosiglitazone Use Surrounding FDA Warnings in the Department of Veterans Affairs
Q37185836Influence of health warnings on the use of rosiglitazone and pioglitazone in an area of Spain: A time-series study
Q50919971Methodological approaches to evaluate the impact of FDA drug safety communications.
Q38807857Novel Therapeutics for Diabetes: Uptake, Usage Trends, and Comparative Effectiveness
Q35792497Rosiglitazone use and associated adverse event rates in Canada: an updated analysis